The University of New England has been awarded $100,000 in grant funding from the U.S. Department of Defense to spearhead innovative research aimed at combating a rare and aggressive form of kidney cancer.
The FY24 Defense Appropriations Act provides funding for the Glioblastoma Research Program to support research of high potential impact and exceptional scientific merit to reduce the burden of glioblastoma on service members and their families, veterans, and the American public. The managing agent for the anticipated program announcements/funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
